Efficacy and tolerability of lumiracoxib, a highly selective cyclo-oxygenase-2 (COX2) inhibitor, in the management of pain and osteoarthritis

Piet Geusens, Willem Lems

Therapeutics and Clinical Risk Management 2008, 4:337-344

Published Date: 11 April 2008